
bluebird bio
@bluebirdbio
Followers
10K
Following
316
Media
899
Statuses
2K
We’re pursuing curative #genetherapies to give patients and their families more bluebird days. Guidelines: https://t.co/QXqQgHMGTC
Somerville, MA
Joined September 2010
“[Living with sickle cell disease] is really hard sometimes because it's an invisible disease and you can’t see when someone is in pain or in need of help. It gets hard because you have to keep explaining to people how you feel, and sometimes they don’t believe you.”
70
5
41
Today bluebird bio announced a definitive agreement to be acquired by Carlyle and SK Capital. Read more in our press release:
investor.bluebirdbio.com
The Investor Relations website contains information about bluebird bio, Inc.'s business for stockholders, potential investors, and financial analysts.
0
4
7
Today, bluebird bio announced it has reached an agreement with the Center for Medicare and Medicaid Innovation to offer an outcomes-based agreement for #sicklecell gene therapy under the Cell and Gene Therapy (CGT) Access Model. “Ensuring timely, equitable access to
11
5
25
Each journey with sickle cell disease is unique. This #WorldSickleCellDay, learn more about Charlotte’s story and how she advocates for the sickle cell community: Meet Charlotte, living with sickle cell disease:
2
3
14
Today, bluebird bio occupies a unique space as a standalone commercial gene therapy company. We are excited to share perspective from a decade of gene therapy leadership and continue learning from other pioneers in the field at #BIO2024. Come say hi if you’ll be in San Diego
2
1
11
Today, bluebird bio reported first quarter 2024 results and business highlights, including the update that we have completed the first commercial cell collection for our sickle cell disease gene therapy. Learn more:
investor.bluebirdbio.com
The Investor Relations website contains information about bluebird bio, Inc.'s business for stockholders, potential investors, and financial analysts.
Today, bluebird bio announces the first person living with sickle cell has initiated treatment with our sickle cell disease gene therapy in the commercial setting. Andrew Obenshain, chief executive officer, shares his reflection on this milestone: “Seeing people living with
2
2
13
Thank you, @MassBio, for featuring bluebird bio as the April MassBio Member Spotlight and for highlighting our leadership and the way the flock keeps patients and families at the heart of everything we do.
Every month, we spotlight a member company and its efforts in advancing the life sciences industry and supporting the patients we serve. In April, we profile @bluebirdbio - the Somerville-based gene therapy company. Read more:
2
0
4
#NewsFromTheNest: Join the bluebird team as they discuss fourth quarter and 2023 annual results and provide a commercial update on Tuesday, March 26 at 8:00 a.m. ET. Learn more:
investor.bluebirdbio.com
The Investor Relations website contains information about bluebird bio, Inc.'s business for stockholders, potential investors, and financial analysts.
0
0
4
As a sickle cell warrior and gene therapy recipient herself, she’s excited to represent the community during this significant moment and speak to the needs of people living with #sicklecelldisease. Watch our Instagram story throughout the day for more:
0
0
3
The flock is headed to Capitol Hill! Follow along and watch our Instagram stories today for a behind-the-scenes look as Jennelle Stephenson prepares to attend the #StateOfTheUnion as a guest of representative Buddy Carter.
2
0
9
Bringing more bluebird days to patients and caregivers impacted by rare diseases is #whywefly. On #RareDiseaseDay, Christina Hartman, Head of Government Affairs and rare mom, shares why she flies for her daughter Charlotte, her community of support, & everyone in the #raredisease
2
1
6
On #MartinLutherKingDay, the flock is encouraged to spend the day reflecting on and celebrating the life and legacy of the Reverend Dr. Martin Luther King, Jr. We encourage you to also take the time to commemorate his work in the fight for civil rights, freedom, and equality.
4
1
7